StockData
Cardio Diagnostics Holdings, Inc. logo

Cardio Diagnostics Holdings, Inc. (CDIO) stock

CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.87−0.05 (-2.60%)

Close on Nov 12, 2026Market cap $5.53MP/E –Yield –

Earnings

Cardio Diagnostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cardio Diagnostics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cardio Diagnostics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cardio Diagnostics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cardio Diagnostics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Leading the Next Frontier in Precision Cardiovascular Medicine 2026 NASDAQ: CDIO 1
    Update
  2. Leading the Next Frontier in Precision Cardiovascular Medicine 2026 NASDAQ: CDIO 1
    Update
  3. DIAGNOSTICS HoldingS, INC. ANNOUNCES 1-for-30 reverse stock split
    Update
  4. COMPANY UPDATE Revolutionizing Cardiovascular Medicine With Epigenetics and AI
    Update
  5. COMPANY UPDATE Revolutionizing Cardiovascular Medicine With Epigenetics and AI MARCH 2024
    Update
  6. Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
    News
  7. 8-K exhibit EX-99.1
    Update
  8. 8-K exhibit EX-99.1
    Update
  9. Cardio Diagnostics Holdings, Inc Announces
    Update
  10. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
    Update
  11. Cardio Diagnostics Holdings, Inc. to List on Nasdaq
    Update
  12. 8-K exhibit EX-99.1
    News
  13. 8-K exhibit EX-99.2
    News
  14. Diagnostics Announces Issuance of U.S. Patent for
    Update
  15. Transforming Cardiovascular Cardiovascular Health Through Our AI - Driven Integrated Genetic - Epigenetic Epigenetic Engine ΠINVESTOR PRESENTATION August 2022 MANA CAPITAL Acquisition Corp.
    Update

See a number that looks wrong?